[1] ANDRES J L, RÖNNSTRAND L, CHEIFETZ S, et al. Purification of the transforming growth factor-β(TGF-β) binding proteoglycan betaglycan[J]. J Biol Chem, 1991, 266(34):23282-23287.
[2] ICHIJO H, HELLMAN U, WERNSTEDT C, et al. Molecular cloning and characterization of ficolin, a multimeric protein with fibrinogen-and collagen-like domains[J]. J Biol Chem, 1993, 268(19):14505-14513.
[3] KILPATRICK D C, CHALMERS J D. Human L-ficolin (ficolin-2) and its clinical significance[J]. J Biomed Biotechnol, 2012, 2012:138797.
[4] BROOKS A S, HAMMERMUELLER J, DELAY J P, et al. Expression and secretion of ficolin β by porcine neutrophils[J]. Biochim Biophys Acta Gen Subj, 2003, 1624(1-3):36-45.
[5] MATSUSHITA M, ENDO Y, TAIRA S, et al. A novel human serum lectin with collagen-and fibrinogen-like domains that functions as an opsonin[J]. J Biol Chem, 1996, 271(5):2448-2454.
[6] MICHALSKI M, ST SWIERZKO A, LUKASIEWICZ J, et al. Ficolin-3 activity towards the opportunistic pathogen, Hafnia alvei[J]. Immunobiology, 2015, 220(1):117-123.
[7] LOZANO V, AGUADO L, HOORELBEKE B, et al. Targeting HIV entry through interaction with envelope glycoprotein 120(gp120):synthesis and antiviral evaluation of 1,3,5-triazines with aromatic amino acids[J]. J Med Chem, 2011, 54(15):5335-5348.
[8] BERTAUX C, DAELEMANS D, MEERTENS L, et al. Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions[J]. Virology, 2007, 366(1):40-50.
[9] HILLAIRE M L B, VAN EIJK M, VOGELZANG-VAN TRIERUM S E, et al. Assessment of the antiviral properties of recombinant surfactant protein D against influenza B virus in vitro[J]. Virus Res, 2015, 195:43-46.
[10] KEIRSTEAD N D, LEE C, YOO D, et al. Porcine plasma ficolin binds and reduces infectivity of porcine reproductive and respiratory syndrome virus (PRRSV) in vitro[J]. Antiv Res, 2008, 77(1):28-38.
[11] HAMED M R, BROWN R J P, ZOTHNER C, et al. Recombinant human L-Ficolin directly neutralizes hepatitis C virus entry[J]. J Innate Immun, 2014, 6(5):676-684.
[12] TAKAHASHI K, MOYO P, CHIGWESHE L, et al. Efficacy of recombinant chimeric lectins, consisting of mannose binding lectin and L-ficolin, against influenza A viral infection in mouse model study[J]. Virus Res, 2013, 178(2):495-501.
[13] VERMA A, WHITE M, VATHIPADIEKAL V, et al. Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses[J]. J Immunol, 2012, 189(5):2478-2487.
[14] MICHELOW I C, DONG M D, MUNGALL B A, et al. A novel L-ficolin/Mannose-binding lectin chimeric molecule with enhanced activity against ebola virus[J]. J Biol Chem, 2010, 285(32):24729-24739.
[15] 张家忠, 章晓联. 纤维胶凝蛋白(ficolin)在非特异性免疫中的作用[J]. 襄樊职业技术学院学报, 2006, 5(5):8-9.
ZHANG J Z, ZHANG X L. The role of ficolin in innate immunity[J]. Journal of Xiangfan Vocational and Technical College, 2006, 5(5):8-9. (in Chinese)
[16] 李兰, 郑其升, 付言峰, 等. 几种胶原样凝集素的生物学特性及其抗病原微生物的作用[J]. 中国兽医杂志, 2016, 52(11):76-78.
LI L, ZHENG Q S, FU Y F, et al. Biological characteristics and antimicrobial activity of several collagen lectins[J]. Chinese Journal of Veterinary Medicine, 2016, 52(11):76-78. (in Chinese)
[17] ENDO Y, IWAKI D, ISHIDA Y, et al. Mouse Ficolin B has an ability to form complexes with mannose-binding lectin-associated serine proteases and activate complement through the lectin pathway[J]. J Biomed Biotechnol, 2012, 2012:105891. |